U.S. FDA Approves New Version of Diabetes Drug Mounjaro for Weight Loss
New diabetes drug Zepbound, also known as tirzepatide, can be sold as a weight-loss drug, helping dieters lose 40-60 pounds.
Massachusetts General Hospital News & Breaking Stories
Consider the Impact of Sleep Dysfunction on Huntington's Disease Patients, Experts Say
A special issue of the Journal of Huntington's Disease has reviewed what is known about sleep and circadian rhythms in Huntington's disease (HD), and what is not known. Sleep disturbances in HD patients are an under-studied field, but there is growing evidence that sleep changes occur early in the clinical course of the disease. Treatment of sleep and circadian disturbances in HD is an unmet need, and intervention studies are needed to investigate the treatment of poor sleep associated with HD.
Get Weekly News Updates
Subscribe to SHUT Newsletter and be up to date with the current events. Be informed, don't settle for fake news.